On the recordDecember 10, 2013
I would suggest a tainted drug is very different from a drug labeling issue.
Source
congress.govI would suggest a tainted drug is very different from a drug labeling issue.
Collins distinguishes between issues of drug safety and labeling.
Share
More from Susan Collins
The bottom line is, I support him when I think he's right. I don't when I think he's wrong.
This $37 million investment will help modernize aging rail infrastructure and increase railcar capacity, making it easier and safer for Maine businesses to move their products.
I vote very independently. ... I am the most bipartisan member of the Senate.